KR102497163B9 - Composition for preventing or treating corona virus comprising Lycorine chloride - Google Patents

Composition for preventing or treating corona virus comprising Lycorine chloride

Info

Publication number
KR102497163B9
KR102497163B9 KR1020200055399A KR20200055399A KR102497163B9 KR 102497163 B9 KR102497163 B9 KR 102497163B9 KR 1020200055399 A KR1020200055399 A KR 1020200055399A KR 20200055399 A KR20200055399 A KR 20200055399A KR 102497163 B9 KR102497163 B9 KR 102497163B9
Authority
KR
South Korea
Prior art keywords
lycorine
chloride
preventing
composition
corona virus
Prior art date
Application number
KR1020200055399A
Other languages
Korean (ko)
Other versions
KR102497163B1 (en
KR20210116152A (en
Inventor
권선오
김승택
김형래
장민성
진영희
김동언
민정선
이지혜
전상은
박철민
이준영
송종환
신영섭
Original Assignee
한국한의학연구원
재단법인 한국파스퇴르연구소
한국화학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국한의학연구원, 재단법인 한국파스퇴르연구소, 한국화학연구원 filed Critical 한국한의학연구원
Publication of KR20210116152A publication Critical patent/KR20210116152A/en
Application granted granted Critical
Publication of KR102497163B1 publication Critical patent/KR102497163B1/en
Publication of KR102497163B9 publication Critical patent/KR102497163B9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/30—Other Organic compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020200055399A 2020-03-16 2020-05-08 Composition for preventing or treating corona virus comprising Lycorine chloride KR102497163B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20200032219 2020-03-16
KR1020200032219 2020-03-16

Publications (3)

Publication Number Publication Date
KR20210116152A KR20210116152A (en) 2021-09-27
KR102497163B1 KR102497163B1 (en) 2023-02-08
KR102497163B9 true KR102497163B9 (en) 2023-05-11

Family

ID=77925863

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200055399A KR102497163B1 (en) 2020-03-16 2020-05-08 Composition for preventing or treating corona virus comprising Lycorine chloride

Country Status (1)

Country Link
KR (1) KR102497163B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102640071B1 (en) * 2023-12-06 2024-02-23 대한민국(질병관리청 국립보건연구원장) Pharmaceutical composition for preventing or treating severe fever with thrombocytopenia syndrome comprising of lycorine hydrochloride as an active ingredient

Also Published As

Publication number Publication date
KR102497163B1 (en) 2023-02-08
KR20210116152A (en) 2021-09-27

Similar Documents

Publication Publication Date Title
MD3710446T2 (en) Compounds useful for inhibiting CDK7
IL288278A (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
SG11202100076RA (en) Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
EP3858353A4 (en) Pharmaceutical composition for preventing and treating nitm and pharmaceutical use thereof
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
IL285886A (en) Compositions and methods for treating laminopathies
IL270070B1 (en) Compounds, compositions and methods of treating or preventing acute lung injury
MX2018014080A (en) Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia.
MX2021006011A (en) An aurora a kinase inhibitor for use in the treatment of neuroblastoma.
KR102497163B9 (en) Composition for preventing or treating corona virus comprising Lycorine chloride
EP3569242A4 (en) Pharmaceutical composition containing sulglycotide or pharmaceutically acceptable salt thereof for preventing or treating dry eye
EP3793539A4 (en) Compounds for treating dengue virus infections and other infections
ZA202202370B (en) Compositions and methods for treating viral infections
EP3827837A4 (en) Composition for preventing or treating immune-related diseases
EP3833387A4 (en) Compositions and methods for preventing and treating virus infection
IL285796A (en) Methods and compositions for treating
MX2018014081A (en) Use of carbamate compound for preventing or treating trigeminal neuralgia.
EP3162803A4 (en) New compound for inhibiting binding between dx2 protein and p14/arf protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient
IL273843A (en) Pharmaceutical compositions for treating corona virus disease covid-19
WO2015122954A3 (en) Protecting tissue and mitigating injury from chemical exposure
ZA202107513B (en) Compounds and compositions comprising the same for treating hypertension or heart failure
KR102455548B9 (en) A Composition for preventing or treating corona virus comprising Levistilide A
EP4058043A4 (en) Compositions and methods for treating or preventing crohn's disease
EP4190916A4 (en) Composition for diagnosing musculoskeletal diseases, composition for preventing or treating musculoskeletal diseases, and use thereof
ZA202007616B (en) Pharmaceutical composition for preventing or treating aids comprising rhodanine derivative

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
G170 Re-publication after modification of scope of protection [patent]